Thrombocythemia Stocks List
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 3.66 | |
FBT | D | First Trust Amex Biotech Index Fund | 3.22 | |
BIS | C | ProShares UltraShort Nasdaq Biotechnology | 2.09 | |
BBH | C | Market Vectors Biotech ETF | 1.76 | |
BBP | C | BioShares Biotechnology Products Fund | 1.69 |
Compare ETFs
- Thrombocythemia
Thrombocythemia (also thrombocytosis) is the presence of high platelet (thrombocyte) counts in the blood, and can be either primary (also termed essential thrombocythemia, and caused by a myeloproliferative disease) or secondary (also termed reactive). Although often symptomless (particularly when it is a secondary reaction), it can predispose to thrombosis in some patients. Thrombocytosis can be contrasted with thrombocytopenia, a loss of platelets in the blood.
In a healthy individual, a normal platelet count ranges from 150,000 and 450,000 per mm³ (or microlitre) (150–450 x 109/L). These limits, however, are determined by the 2.5th lower and upper percentile, and a deviation does not necessary imply any form of disease. Nevertheless, counts over 750,000 (and especially over a million) are considered serious enough to warrant investigation and intervention.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles